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Abstract
Background: Bacterial meningitis remains a source of substantial morbidity and mortality in childhood. During the last
decades gradual changes have been observed in the epidemiology of bacterial meningitis, related to the introduction of
new polysaccharide and conjugate vaccines. The study presents an overview of the epidemiological patterns of acute
bacterial meningitis in a tertiary children 's hospital during a 32-year period, using information from a disease registry.
Moreover, it discusses the contribution of communicable disease registries in the study of acute infectious diseases.
Methods: In the early 1970s a Meningitis Registry (MR) was created for patients admitted with meningitis in Aghia Sofia
Children's Hospital in Athens. The MR includes demographic, clinical and laboratory data as well as treatment,
complications and outcome of the patients. In 2000 a database was created and the collected data were entered, analyzed
and presented in three chronological periods: A (1974–1984), B (1985–1994) and C (1995–2005).
Results: Of the 2,477 cases of bacterial meningitis registered in total, 1,146 cases (46.3%) were classified as "probable"
and 1,331 (53.7%) as "confirmed" bacterial meningitis. The estimated mean annual Incidence Rate (IR) was 16.9/100,000
for bacterial meningitis, 8.9/100,000 for Neisseria meningitidis, 1.3/100,000 for Streptococcus pneumoniae, 2.5/100,000 for
Haemophilus influenzae type b (Hib) before vaccination and 0.4/100,000 for Hib after vaccination. Neisseria meningitis
constituted the leading cause of childhood bacterial meningitis for all periods and in all age groups. Hib was the second
most common cause of bacterial meningitis before the introduction of Hib conjugate vaccine, in periods A and B. The
incidence of bacterial meningitis due to Streptococcus pneumoniae was stable. The long-term epidemiological pattern of
Neisseria meningitidis appears in cycles of approximately 10 years, confirmed by a significant rise of IR in period C. The
Case Fatality Rate (CFR) from all causes was 3.8%, while higher CFR were estimated for Streptococcus pneumoniae (7.5%,
RR=2.1, 95% CI 1.2–3.7) and Neisseria meningitidis (4.8%, RR=1.7, 95% CI 1.1–2.5) compared to other pathogens.
Moreover, overall CFR varied significantly among the three time periods (p = 0.0015), and was estimated to be higher in
period C.
Conclusion: By using the MR we were able to delineate long-term changes in the epidemiology of bacterial meningitis.
Thus the MR proved to be a useful tool in the study and the prevention of communicable diseases in correlation with
prevention strategies, such as vaccinations.
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Background
In the pre-antibiotic era, bacterial meningitis was a fatal
disease. In our days, despite increased availability of
potent antimicrobials and sophisticated intensive care
units, bacterial meningitis continues to be a significant
cause of childhood morbidity and mortality [1,2]. This is
reflected in the fact that meningitis continues to be
present in the ten leading causes of death in children of
high-income countries [3].
Many clinical and etiologic studies performed over the
past 30 years have demonstrated that Haemophilus influen-
zae type b (Hib), Neisseria meningitidis and Streptococcus
pneumoniae were the most common causative organisms
of bacterial meningitis worldwide [1,2,4]. The develop-
ment and implementation of a conjugate vaccine against
Hib in the early 1990's have contributed directly to
changes in the epidemiological profile of meningitis
caused by Hib, in the countries that adopted universal
immunization [4-6]. More recently, serogroup C menin-
gococcal conjugate vaccine and pneumococcal heptava-
lent conjugate vaccine were licensed and are expected to
influence the epidemiology of the disease. Therefore, a
review of the epidemiology of bacterial meningitis is
important in order to make rational decisions concerning
future prevention and control strategies.
In Greece, studies on the epidemiology of childhood bac-
terial meningitis have largely focused on single causative
organisms and specific geographic areas, while a nation-
wide surveillance system was not established before 1993
– when the National Meningococcal Reference Laboratory
became operative.
Medical registries are defined as records of all new cases of
selected diseases in defined populations that are prospec-
tively monitored. They have been extensively used in the
research of chronic diseases, while also communicable
disease registries are being increasingly used. In the early
1970s, the creation of a Meningitis Registry (MR) in the
Infectious Diseases Department of Aghia Sofia Children's
Hospital in Athens, responded to the need for compre-
hensive epidemiological information on childhood men-
ingitis in Greece. This report presents the 32-year MR
findings regarding the epidemiological features of bacte-
rial meningitis.
Methods
Study setting
Aghia Sofia Children's Hospital is a 250-bed pediatric uni-
versity teaching hospital, which serves as a major referral
center. The hospital has an average of 20,000 admissions
annually, 4% of them treated in the Infectious Diseases
Department. It is important to mention that Athens met-
ropolitan pediatric population is covered by two more
pediatric hospitals and few pediatric clinics located in
general hospitals.
Nevertheless, the majority of meningitis cases occurring in
Athens metropolitan area, as well as those referred from
central and south Greece and most of the Aegean Sea
islands of the country were transferred and treated in the
Infectious Diseases Department of Aghia Sofia Children's
Hospital. During the last decade this pattern has changed,
leading to a more wide distribution of meningitis cases at
different facilities and a subsequently increasing number
of meningitis cases treated in the other pediatric clinics.
Taking into account the above information, it is postu-
lated that, concerning specifically meningitis cases, the
hospital served approximately 100% of the pediatric pop-
ulation of metropolitan Athens in period A, approxi-
mately 65% in period B and approximately 55% in period
C.
Data collection
In the early 1970s, a MR was created for patients admitted
with meningitis in the Infectious Diseases Department of
Aghia Sofia Children's Hospital. In the Registry Form (RF)
around 50 parameters were included: demographic data
(full name, sex, date of birth, father occupation, home
address, telephone number, date of entry and date of dis-
charge) and clinical data (preadmission antibiotic ther-
apy, comorbid conditions, fever, headache, vomiting,
meningeal signs, petecchiae, seizures, bulging fontanelle,
grumbling, poor feeding, collapses or coma – on the day
of admission, as well as for the following days). Moreover
MR included laboratory results from Cerebrospinal Fluid
(CSF) examination (white cell count, polymorphonuclear
and lymphocyte count, glucose, protein, Gram stain, cul-
ture, latex, Polymerase Chain Reaction [PCR]), blood
examination (hemoglobin, haematocrit, white cell count,
polymorphonuclear and lymphocyte count, culture, PCR,
prothrombin time), urine analysis, nasopharyngeal cul-
ture, stool culture and Mantoux. Finally, type and dura-
tion of provided treatment, discharge diagnosis, outcome
and sequelae were recorded.
For each case the attending physician completed the RF
upon discharge of the patient. Follow up visits were held
up to 3 months after discharge and all additional informa-
tion was recorded. To attain completeness, RFs were also
created for two categories of patients who died from bac-
terial meningitis in the hospital without being treated in
the Infectious Diseases Department. The Intensive Care
Unit (ICU) records were reviewed to identify patients who
were admitted directly to the ICU and died there from
bacterial meningitis. Secondly, patients who died in the
emergency department or were dead on admission with
signs of bacterial meningitis or meningococcal septicemia
were also recorded, after the review of hospital deathBMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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records. Despite those cases were not hospitalized, a spe-
cial RF was created and was included in the MR.
In 2000 a computerized database was created using Epi-
nfo epidemiological package (version 3.3.2 – CDC –
Atlanta) and for one year the already compiled RFs were
entered into the database. Moreover, RFs were entered
prospectively for the years 2000–2005.
Case definition – Inclusion criteria
A "case" was defined as any patient treated in the Infec-
tious Diseases Department of Aghia Sofia Children's Hos-
pital from January 1st 1974 until December 31st 2005,
who was aged one-month-old to fourteen-years-old and
was diagnosed with bacterial meningitis.
"Probable" bacterial meningitis cases were defined -
according to World Health Organization (WHO) criteria-
those presenting clinical symptoms of meningitis (i.e.
fever, headache, stiff neck, bulging fontanel or altered
mental status) and CSF with an elevated protein (> 100
mg/dl), decreased glucose (< 40 mg/dl) or leukocytosis (>
100 WBC/mm3) with at least 80% neutrophils and lack-
ing an identifiable bacterial pathogen [7].
"Confirmed" bacterial meningitis cases were defined
according to WHO case definition criteria [7]: children
presenting with clinical symptoms of meningitis (i.e.
fever, headache, stiff neck, bulging fontanelle or mental
status changes) and identification of bacteria directly (by
culture or PCR from blood or CSF, or by culture from the
petecchial lesions), or indirectly (by latex test, countercur-
rent immunoelectrophoresis, Fadebact, or Gram stain
smear of blood or CSF). The "Confirmed" bacterial men-
ingitis cases were further divided into the following
groups, representing the most commonly isolated patho-
gens: Neisseria meningitidis, Streptococcus pneumoniae, Hae-
mophilus influenzae type b and a fourth group "confirmed
bacterial meningitis due to other bacteria" including all
other isolated pathogens.
"Probable" meningococcal meningitis cases were defined
-according to WHO case definition- those with clinical
findings (fever > 38°C, hemorrhagic rash, circulatory col-
lapse or coma) and laboratory findings compatible with
meningococcal meningitis disease (CSF protein > 100
mg/dl, CSF glucose < 40 mg/dl or > 100 CSF WBC/mm3
with at least 80% neutrophils), although Neisseria menin-
gitidis had not been isolated [8].
Deaths were attributed to bacterial meningitis if the
patient died within one month of receiving in hospital
antimicrobial therapy in hospital and if bacterial menin-
gitis was the direct or predisposing cause of death.
Exclusion criteria
All patients that had been diagnosed repeatedly with
events of bacterial meningitis due to structural defects of
the central nervous system were excluded from the study.
Meningitis cases caused by Mycobacterium tuberculosis were
also excluded, as well as cases of patients younger than 1
month old.
Study periods
In order to facilitate data analysis and taking into consid-
eration the fact that the conjugate Hib vaccine was intro-
duced in Greece in mid 1994, cases were divided by date
of admission, in three time periods (of 11, 10 and 11 years
respectively): period A (1974 – 1984), period B (1985 –
1994) and period C (1995–2005). Periods A and B corre-
spond to the time before the implementation of conjugate
Hib vaccine, while period C corresponds to the time when
immunization for Hib was practiced routinely in Greece.
Data analysis
Statistical analyses were performed with Epi-nfo epidemi-
ological package (version 3.3.2 – CDC – Atlanta). The chi-
square test and the Fischer exact test were used to compare
qualitative variables. All results for continuous variables
are expressed as means (Standard Deviation, SD). The stu-
dent t-test, or Mann-Whitney test were used for quantita-
tive variables. The level of 0.05 was used for statistical
significance. Risk ratio (RR) with 95% confidence inter-
vals (95% CI) were also calculated. Annual incidence was
calculated per 100,000 children less than 14 year of age
served by Aghia Sofia Children's Hospital. Population fig-
ures were extrapolated based on 1971, 1981, 1991 and
2001 census [9-12]. Potential years of life lost were calcu-
lated using the WHO life expectancy at birth for males and
females in Greece [13].
Results
During the 32 years of the MR a total of 3,495 cases were
recorded, 2,477 (70.87%) of which met the criteria for
bacterial meningitis. "Probable bacterial meningitis cases"
were considered 1,146 (46.3%), while "confirmed bacte-
rial meningitis cases" were considered 1,331 (53.7%). A
single bacterial organism was identified in all "confirmed
bacterial meningitis cases". The organism was identified
directly in 1,073/1,331 cases (80.6%) out of which 789/
1,073 cases (73.5%) were found positive only in CSF cul-
ture, 183/1,073 (17.1%) were found positive both in CSF
and blood culture, whereas the remaining 101/1,073
(9.4%) were positive only in blood culture. A total of 258/
1,331 cases (19.4%) were identified indirectly.
The agents most commonly associated with bacterial
meningitis were Neisseria meningitidis (Incidence Rate [IR]
8.9 per 100,000 children), Hib (IR 1.7 per 100,000 chil-
dren) and Streptococcus pneumoniae (IR 1.3 per 100,000BMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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children), while in 30% of cases no bacterial pathogen
was identified. Total number and mean annual IR of bac-
terial meningitis cases in the three periods of the study are
presented in Table 1. Moreover, the yearly distribution of
IR of bacterial meningitis according to pathogenic agent is
shown in Figure 1.
Males (58.7%) outnumbered females overall, while the
mean annual IR of bacterial meningitis (per 100,000 chil-
dren) was estimated 19.1 for males and 14.6 for females.
Age specific rates for bacterial meningitis varied with path-
ogen (Table 2). The mean age was 3.1 years (SD 3.6;
median 2; range 1 month to 14 years). Younger than 5
years were 71.4% of patients (1,718 out of the 2,406 chil-
dren whose age was available). Patients aged < 1 year
accounted for one third (786 – 32.7%), while patients 10
years and older accounted for 8.6% of the series.
During the 32 years of the study, 95 patients died in total.
The Case Fatality Rate (CFR) of bacterial meningitis from
all causes was estimated 3.8% (95% CI 3.1–4.7) The CFR
varied significantly according to organism (p = 0.0001)
and among the three time periods (p = 0.0015). The CFR
was estimated higher during period C (5.4%, 95% CI 3.7–
7.7) compared to periods A and B (RR 1.4, 95% CI 1.0–
1.9), while CFR was estimated lower during period B
(1.5%, 95% CI 0.7–2.9) compared to periods A and C (RR
0.4, 95% CI 0.2–0.7). The potential years of life lost were
7,250 in total. Potential years of life lost per period were
estimated as follows: A 4,320, B 700 and C 2,230. The
mean length of hospitalization was 11.7 days (SD 6.1)
and decreased gradually from period A to period C 12.4,
11.8 and 9.7 days respectively (p < 0.0001). Moreover,
infants under 1 year of age were hospitalized for longer
(14.0 days) compared to older children (p < 0.0001).
Patients who died from bacterial meningitis were hospi-
talized for a mean 3.8 days (SD 6.7 days), ranging from 0
to 38 days. Only one patient who died, in period A, from
pneumococcal meningitis complicated with subdural
effusion was hospitalized for more than one month. Table
3 presents the absolute number of fatal cases, CFR and
mean duration of hospitalization.
All pathogens showed some seasonal variation. Sixty-nine
percent (69.0%) of the cases were diagnosed between
October and April. Monthly distribution of Neisseria men-
ingitidis, Streptococcus pneumoniae and Hib is presented in
Figure 2.
Neisseria meningitidis
Meningococci constituted the leading cause of bacterial
meningitis cases treated in the Infectious Diseases Depart-
ment of Aghia Sofia Children's Hospital, during the last
three decades and in all age groups. More than half of bac-
terial meningitis cases registered were attributed to Neisse-
ria meningitidis (1,252 out of 2,477 – 50.5%). The mean
Table 1: Bacterial meningitis in three periods according to pathogen
Organism 1974–1984 1985–1994 1995–2005 Total
N% I R * N % IR* N % IR* N % IR*
N. meningitidis- probable 238 18.0 3.4 63 10.5 1.6 113 20.3 3.3 414 16.7 2.8
N. meningitidis- confirmed 386 29.3 5.5 197 32.8 5.2 255 45.7 7.6 838 33.8 6.1
N. meningitidis- total 624 47.3 8.9 260 43.3 6.8 368 65.9 10.9 1252 50.5 8.9
S. pneumoniae 90 6.8 1.3 46 7.7 1.2 50 9.0 1.5 186 7.5 1.3
H. influenzae type b 100 7.6 1.4 138 23.0 3.6 14 2.5 0.4 252 10.2 1.7
Other bacteria*** 29 2.2 0.4 13 2.2 0.3 13 2.3 0.4 55 2.2 0.4
Unspecified** 476 36.1 6.7 143 23.8 3.6 113 20.3 3.3 732 29.6 4.6
Total 1319 100 18.7 600 100 15.5 558 100 16.5 2477 100 16.9
* Mean annual Incidence Rate per 100,000 children
** "Probable" bacterial meningitis cases not including "probable" meningococcal meningitis cases
*** group B Streptococcus, Salmonella spp, Streptococcus spp, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus spp, Brucella melitensis, Klebsiella 
pneumoniae, Acinetobacter anitratus, Enterobacter cloaca, Mycoplasma pneumoniae, Proteus spp, Rickettsiae spp
IR of bacterial meningitis according to etiology from 1974 to  2005 Figure 1
IR of bacterial meningitis according to etiology from 1974 to 
2005.
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annual IR of total meningococcal meningitis cases was
estimated 8.9 per 100,000 children. In the third period a
38.0% increase of the mean annual IR was estimated
(from 7.9 in periods A and B to 10.9 per 100,000 children
in period C). This rise was more pronounced in patients
with confirmed meningococcal meningitis (Table 1).
Most cases due to Neisseria meningitidis occurred in infants
and young children: 26.3% occurred in infants < 1 year
and 71.1% in children < 5 years of age. Infants < 1 year of
age had the highest age specific IR (32.8, 27.9 and 18.9 per
100,000 children in periods A, B and C). The mean age of
Neisseria meningitidis cases, approximately 2.7 years (SD
3.2) in periods A and B, marked a significant increase in
period C up to 4.9 years (SD 3.9), as presented in Figure 3
(p < 0.0001). This observation applies, to "confirmed"
and "probable" meningococcal disease as well. In total,
males (55.1%) outnumbered females.
The overall CFR for Neisseria meningitidis was estimated
4.8% (95% CI 3.7–6.2), while it was estimated 1.7%
(95% CI 1.0–2.9) for "confirmed" meningococcal menin-
gitis. The higher CFR (11.1%, 95% CI 8.3–14.6) was
observed in the "probable" Neisseria meningitidis cases
compared to all other bacterial meningitis cases (RR 4.7,
95% CI 3.2–6.9). Interestingly, higher rates of case fatality
were estimated in period C (6.3%, 95% CI 4.1–9.4), com-
pared to 5.3% (95% CI 3.7–7.4) and 1.5% (95% CI 0.4–
3.9) in periods A and B. Age specific CFR was higher in the
1–4 years (7.4%, 95% CI 3.6–13.2) and 10–14 years
(10.0%, 95% CI 3.8–20.5) age groups.
Of the 838 confirmed meningococcal meningitis cases
serogroup was available for only 321 (38.3%), with the
predominant isolates being B (58.6%), C (23.4%) and A
(10.9%). Serogroup differed among the three periods of
the study. In period A 75 cases (70.8%) of serogroup B, 16
cases (15.1%) of serogroup A and 13 cases (12.3%) of
serogroup C were isolated. Correspondingly, in period B
34 cases (49.3%) of serogroup B, 32 cases (46.4%) of
serogroup C and 1 case (1.4%) of serogroup A were iso-
lated. Finally, in period C 79 cases (54.1%) of serogroup
B, 30 cases (20.5%) of serogroup C and 18 cases (12.3%)
of serogroup A were isolated.
Meningococcal meningitis cases demanded the shortest
duration of hospitalization (10.5 ± 5.1 days) among all
other causes (Table 3). A seasonal pattern of meningococ-
Monthly variation of the three most common pathogens of  bacterial meningitis Figure 2
Monthly variation of the three most common pathogens of 
bacterial meningitis.
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Table 2: Meningitis cases in the three most common pathogens according to age group, in three periods
Organism N. Meningitidis* S. Pneumoniae H. Influenzae
Age 
Group
Period N % IR** N% I R ** N% I R **
1 to 11  1974–1984 202 63.3 32.8 45 60.8 7.3 41 40.2 6.5
months 1985–1994 69 21.6 27.9 15 20.3 5.6 55 53.9 22.9
1995–2005 48 15.0 18.9 14 18.9 5.5 6 5.9 2.3
1 to 4  1974–1984 274 50.3 14.4 26 38.8 1.3 49 38.6 2.6
years 1985–1994 136 25.0 16.7 14 20.9 1.7 72 56.7 8.7
1995–2005 135 24.8 16.3 27 40.3 3.3 6 4.7 0.7
5 to 9  1974–1984 93 38.4 4.1 10 40.0 0.4 7 43.8 0.3
years 1985–1994 38 15.7 3.0 8 32.0 0.6 8 50.0 0.6
1995–2005 111 45.9 10.1 7 28.0 0.6 1 6.3 0.1
10 to 14  1974–1984 36 33.0 1.6 7 46.7 0.3 1 50.0 0.0
years 1985–1994 13 11.9 0.9 7 46.7 0.5 1 50.0 0.0
1995–2005 60 55.0 5.1 1 6.7 0.1 0 0.0 0.0
Total 1974–2005 1252 100.0 8.9 186 100.0 1.3 252 100.0 1.7
* N. Meningitidis includes probable and confirmed meningococcal meningitis cases
** Mean annual Incidence Rate per 100,000 childrenBMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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cal meningitis was observed, with a peak during winter
and spring, presenting a maximum from January to March
(Figure 2).
Streptococcus pneumoniae
Pneumococcal meningitis occurred in 186 cases out of
2,477. The mean annual IR in total was 1.3 per 100,000
children. The incidence of pneumococcal meningitis
remained relatively stable during the three periods of the
study. Overall, the risk of meningitis from Streptococcus
pneumoniae was higher in the < 1 year and < 5 years age
groups. The mean annual IR observed in infants < 1 year
of age was 7.3, 5.6 and 5.5 per 100,000 in the three peri-
ods. Respectively, IR in children < 5 years of age was esti-
mated 2.8, 1.8 and 2.1 per 100,000 children for periods A,
B and C.
Streptococcus pneumoniae meningitis affected children with
a mean age of 2.7 years (SD 3.6), which varied from 2.2,
3.7 and 2.4 in periods A, B and C respectively. Two thirds
of pneumococcal meningitis cases were males (male to
female ratio 2.1:1).
The overall CFR was 7.5% (95% CI 4.2–12.3), which was
the highest among the three most common pathogens
(RR 2.1, 95% CI 1.2–3.7). Interestingly, no casualty was
recorded from pneumococcal meningitis during period B,
while the CFR increased significantly during period C
(CFR in period A 7.8%, period B 0%, period C 14.0%).
The duration of hospitalization (including casualties) was
15.8 ± 9.4 days, the second longer following "other bacte-
rial organisms" (Table 3).
The majority of cases (127 out of 186, 68.3%) manifested
between October and March, presenting with a bimodal
pattern. One peak was noticed during autumn, in October
and November, and a second occurred during spring, in
March (Figure 2).
Haemophilus influenzae type b
Haemophilus influenzae type b was responsible for 252
meningitis cases, constituting the second most common
etiologic agent, in the fist two periods of the study. The IR
of Hib meningitis began a noticeable decline after 1994,
the year that the Hib conjugate vaccine was introduced.
The mean annual IR for Hib before the vaccination was
estimated 2.5 per 100,000 children: rather low in period
A (1.4 per 100,000 children) and higher in period B (3.6
per 100,000 children). A fall up to 0.4 per 100,000 chil-
dren was observed during period C. In particular, in the
children < 5 years of age the mean annual IR was esti-
mated 3.5 per 100,000 children in period A, 8.0 in period
Mean age of meningococcal cases from 1974 to 2005 Figure 3
Mean age of meningococcal cases from 1974 to 2005.
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Table 3: Case fatality rate and duration of hospitalization
Case fatalities Days of hospitalization
Organism N CFR% (95% CI) Relative Risk 
(95% CI)
Mean (SD) Range N
N. meningitidis – 
probable
46 11.1 (8.3–14.6) 4.7 (3.2–6.9)
N. meningitidis- 
confirmed
14 1.7 (1.0–2.9) 0.3 (0.2–0.6)
N. meningitidis- 
total
60 4.8 (3.7–6.2) 1.7 (1.1–2.5) 10.5 (5.1) 0 – 65 1242
S. pneumoniae 14 7.5 (4.2–12.3) 2.1 (1.2–3.7) 15.8 (9.4) 0 – 95 184
H. influenzae 
type b
2 0.8 (0.1–2.8) 0.2 (0.0–0.8) 14.5 (5.1) 1 – 47 252
Other bacteria 4 7.3 (2.0–17.6) 1.9 (0.7–5.1) 20.3 (12.4) 0 – 68 53
Unspecified 15 2.0 (1.2–3.4) 0.4 (0.3–0.8) 11.2 (5.1) 0 – 48 725
Total 95 3.8 (3.1–4.7) 11.7 (6.1) 0 – 95 2456BMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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B and 0.6 in period C, presenting with an estimated
92.5% decline from period B to C.
The mean age of children affected by Hib meningitis was
1.3 years (SD 1.9), quite lower compared to the age of
children affected by Neisseria meningitidis and Streptococcus
pneumoniae. The 41.3% and 51.4% of children affected by
Hib meningitis were aged < 1 year and 1–4 years respec-
tively. Males (57%) were more numerous than females.
The CFR of Hib (0.8%, 95% CI 0.1–2.8) was found lower
than the CFR of other pathogens (RR 0.2, 95% CI 0.0–
0.8). All deaths from Hib occurred during the first period
(CFR in period A 2.0%, 95% CI 0.2–7.0) and concerned
children with a mean age of 8 months (SD 2.8 months,
range 6–10 months). The estimated CFR in the children <
1 year and < 5 years of age was 2.0% (95%CI 0.2–6.9%)
and 0.9% (95% CI 0.1–3.1) respectively.
Patients with Hib meningitis were hospitalized for a mean
14.5 ± 5.1 days, 4.0 days more than meningococcal men-
ingitis (Table 3).
A seasonal variation in Hib meningitis cases was
observed, presenting with two peaks, the first in late
autumn and the second in the early spring (Figure 2).
Bacterial meningitis due to other organisms
In total 55 cases were recorded which are being analyzed
in Table 1. The overall IR of this category was 0.4 cases per
100,000 children, and was stable during all periods of the
study. Group B Streptococcus was the most frequently iso-
lated pathogen. Mean age of patients affected by "other
bacterial organisms" was 1.3 years (SD 2.8), ranging from
1.0 month up to 11.0 years. In the four age groups (1–11
months, 1–4 years, 5–9 years and 10–14 years) the fre-
quency of "other bacterial pathogens" was 77.4%, 7.5%,
11.3% and 3.8% respectively. Male predominance was
noted (63.6%).
The overall CFR was 7.3% (95% CI 2.0–17.6), almost
double compared to the average CFR estimated for bacte-
rial meningitis (RR 1.9, 95% CI 0.7–5.1). The CFR for
Escherichia coli was estimated 20% and the CFR for Salmo-
nella spp was estimated 18.2%. All 4 deaths from bacterial
meningitis due to "other bacteria" occurred during the
first 2 periods of the study. Duration of hospitalization
was longer (20.3 ± 12.4 days) for children with meningitis
due to "other bacteria", compared to Streptococcus pneumo-
niae and Hib (15.8 ± 9.4 and 14.5 ± 5.1 days respectively)
as shown in Table 3 (p < 0.0001). No seasonal pattern was
observed.
Bacterial meningitis due to unspecified pathogens
A total of 732 cases out of 2,477 (29.6%) were classified
as "probable" bacterial meningitis. The overall IR of this
category was 4.6 cases per 100,000 children. A significant
decline was observed in the mean annual IR from period
A (6.7 per 100,000 children) to period B (3.6 per 100,000
children), followed by a slight further decrease in period
C (3.3 per 100,000 children).
The mean age of patients in this group was 3.7 years (SD
3.9), while the different age groups were represented as
follows: < 1 year 35.2%, 1–4 years old 26.6%, 5–9 years
old 26.9% and 10–14 years old 11.3%. Male to female
ratio was estimated 1.7:1.
The overall CFR was estimated 2.0% (95% CI 1.2–3.4).
No death in "probable" bacterial meningitis group was
recorded during period C. Mean duration of hospitaliza-
tion was 11.2 ± 5.1 days, ranging from 0 to 48 days.
Discussion
This comprehensive study examined the epidemiological
features of acute bacterial meningitis cases that were
treated in a tertiary children's hospital from 1974 to 2005,
using information prospectively collected through a MR.
Neisseria meningitidis was determined as the main patho-
gen involved into the aetiology of bacterial meningitis in
children throughout the 32 years of the study. Changes in
the IR of bacterial meningitis, during the 3 periods that
were examined, reflect the significant decline of Hib men-
ingitis cases following the routine implementation of Hib
conjugate vaccine, as well as the natural fluctuation of
meningococcal meningitis. The estimated CFR of bacterial
meningitis (3.8%, 95% CI 3.1–4.7) was comparable to
the mean mortality rate for children reported in a meta-
analysis of prospective cohorts from developed countries
(4.8%, 95% CI 3.1–6.3) [14]. Other authors report CFRs
up to 24% [15].
Neisseria meningitidis
Neisseria meningitidis was found to be the leading cause of
childhood bacterial meningitis in the present study dur-
ing all periods and in all age groups. This finding is in line
with the reports from the National Meningococcal Refer-
ence Laboratory (data for all age groups from 1997
onwards [16]) and with previous reports from specific
geographic areas of the country [17-19]. In contrast to the
above observation, many countries worldwide report Hib
to be the most common cause of bacterial meningitis
among children, in the period before the introduction of
Hib vaccines [20-25]. Other countries report meningococ-
cal meningitis to be the major cause of bacterial meningi-
tis in young children, such as Scotland [25], Bulgaria [26]
and Nigeria [27].BMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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In common with other studies, it was found that the risk
of meningococcal meningitis was higher in infants and
young children aged < 5 years [25,28]. The statistically sig-
nificant increase in the number of cases during period C
was linked to the introduction of the new epidemic clone
of Neisseria meningitidis C:2a:P1.2 in the years 1996–1997
[29,30], responsible for disease outbreaks also in the
Czech Republic and Canada [31,32]. As already discussed,
this could reflect the epidemiological pattern of meningo-
coccal disease that appears in cycles of approximately 8–
12 years [8,33]. Current findings also confirm the well-
known fact that introduction of a new virulent clone in a
community is followed by a shift in the age distribution
towards toddlers and pre-schoolers [8,29,34]. In sporadic
conditions the highest rates occur in young children.
Mean age of Neisseria meningitidis cases increased in the
current study from 2.7 (in periods A and B) to 4.9 years
(in period C), as shown in Figure 3. In accordance with
previous reports higher case fatality rates (6.3%) were esti-
mated in period C, compared to 5.3% and 1.5% respec-
tively in periods A and B [16,29]. This rise of CFR is
considered as being related to the emerging new epidemic
clone. A high fatal outcome from meningococcal menin-
gitis (10%) was noticed in the 10–14 years age group dur-
ing period C.
Corresponding to the findings of other reports [28,35],
the remarkably high (11.1%) CFR of "probable" Neisseria
meningitidis cases estimated represents the fulminant and
acute clinical forms of the disease. In the majority of these
cases clinical evolution was so rapid and devastating that
antibiotic treatment was administered prior to the lumbar
puncture, leading to decreased isolation rates. The intro-
duction of more sophisticated diagnostic techniques
(such as Elisa and PCR), and probably an increase in the
sensitivity of classical methods (e.g. CSF and blood cul-
tures) contributed to the reduction by 73.5% of the "prob-
able Neisseria meningitis" cases from period A to period B.
According to our findings the main serogroups isolated
throughout the study were A, B and C. Serogroup B was
most commonly isolated during periods A and C, while
during period B serogroups B and C presented with com-
parable rates (49.3% and 46.4%). The increase of sero-
group C during 1996–7 that has been reported [16,29] is
not reflected in our data, since we are analyzing cumula-
tive data for 10 years and not analyzing data by year. Note-
worthy is the considerable contribution of serogroup A in
periods A and C (15.1% and 12.3%). The re-emergence of
serogroup A in the late 1990s has been hypothesized to be
linked to immigrants moving to Greece from Eastern
European countries, where serogroup A is known to be
prevalent [36].
Streptococcus pneumoniae
Meningitis accounts for 10–16% of invasive pneumococ-
cal disease [37]. In our series Streptococcus pneumoniae was
responsible for a relatively stable proportion of bacterial
meningitis cases throughout the 32 years of the study.
During the last decade, following the introduction of Hib
conjugate vaccine, pneumococci became the second most
common etiologic agent of childhood bacterial meningi-
tis. IR estimated for pneumococcal meningitis was slightly
lower than previously reported for pediatric population in
Greece [38]. The small difference between the IR in the
two studies is possibly due to the fact that although they
were implemented in the same hospital, a different catch-
ment was used in order to estimate the reference popula-
tion, 55% in the current study and 45% in the older study.
Comparable IRs (1.6 and 1.63 per 100,000) are reported
from England and Wales and Germany for children aged
< 15 and < 16 years respectively [39,40]. In the present
study the higher age specific IR was estimated in infants
1–11 months, ranging from 7.4, 5.6 and 5.5 per 100,000
children in periods A, B and C respectively. Similar find-
ings from Europe report the CFR of children < 1 year rang-
ing from 6.1 to 17.8 per 100,000 children depending on
the country and the study [25,41-44].
The CFR for pneumococcal meningitis was estimated to
be almost double of that of bacterial meningitis in total.
Comparable CFR has been reported previously from other
studies in Greece [38] and the United States [37]. Other
studies mention higher CFR up to 16% for childhood
pneumococcal meningitis [44]. High mortality of pneu-
mococcal meningitis should be further investigated and to
be set as a priority towards the development of improved
preventive as well as therapeutic approaches.
Male to female ratio estimated in the present study
exceeds by far the previously reported in Greece (2.1:1 and
1.4:1 respectively) [38]. Moreover, the mean age of chil-
dren affected by pneumococcal meningitis was found
higher than previously reported. The bimodal seasonal
variation observed was consistent with other reports
[38,43].
Although the heptavalent Streptococcus pneumoniae conju-
gate vaccine became available in the country in 2003, vac-
cination coverage was low during the study period.
Currently presented data could prove valuable in order to
compare the burden of pneumococcal meningitis in
Greece before and after the implementation of conjugate
pneumococcal vaccine.
Haemophilus influenzae type b
The overall annual incidence for Hib meningitis in chil-
dren aged 0 to 4 years in the pre-vaccination era ranged in
Europe from 11 to 40 per 100,000 with an estimated aver-BMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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age of 23 per 100,000 [5]. The reported IR of Hib menin-
gitis in Greece in children 0 to 4 years of age before the
introduction of Hib conjugate vaccine was 8.0 per
100,000 [17,45], the lowest IR observed in Europe. Sev-
eral southern European and Mediterranean countries, as
well as Japan, presented with comparable rates
[26,46,47]. Findings from the present study during period
B agree with previous reports from Greece during the pre-
vaccination era [17,45]. As a result it is believed that Hib
IRs during period A are underestimates. This could be
attributed to improved diagnostic techniques that con-
tributed to higher isolation and identification rates and
the decline of cases of "unspecified etiology" noted in
period B (Table 1).
Following the introduction of the new conjugate Hib vac-
cine in the late 1993 in Greece, a dramatic decline
(92.5%) of Hib meningitis cases was noted in period C.
Similar findings have been recorded in the United States
[24], Canada [48] and several European countries
[46,49,51], with reduction levels up to 98%.
During period C a total of 14 cases of Hib meningitis were
recorded. Among these 14 cases during period C, 4 were
recorded in 1995, 4 in 1996, 1 in 1998, 2 in 2000, 2 in
2002 and 1 in 2003, the last being the latest Haemophilus
influenzae type b meningitis case treated in the infectious
diseases department of Aghia Sofia Children's Hospital up
to now. In line with other reports it was shown that more
than 90% of Hib meningitis occurs in the < 5 years patient
group 52–54].
The CFR estimated in the present study (0.8% in all ages
and 0.9% in children < 5 years of age) was found lower
compared to CFR reported from developed countries
(5%) [5]. It is noteworthy that all Hib meningitis fatalities
occurred in children during the first year of life, an obser-
vation that justifies the introduction of immunization
early in infancy.
According to our data, emergence of other serotypes of
Haemophilus influenza did not occur following the routine
use of Hib conjugate vaccine.
Other bacteria
Bacterial meningitis due to other bacteria affects mainly
children in the first two years of life, probably reflecting
the immaturity of the immune system of the host. Most
authors report similar pathogens to our findings, includ-
ing gram-negative and gram-positive bacteria as etiologic
agents of bacterial meningitis [15,20,48]. An important
observation is theoccurrence of some rare pathogens such
as Brucella melitensis, Mycoplasma pneumoniae and Rickett-
siae spp, which are uncommon causes of meningitis in
childhood. Interestingly, the IR of meningitis due to other
bacteria remained relatively stable during the three dec-
ades of the study, indicating that this category was not
influenced by the improvement of diagnostic techniques
with time.
Bacterial meningitis due to unspecified pathogens
Approximately one out of three meningitis cases were reg-
istered as "probably" bacterial in origin, since no patho-
gen was isolated. The decline in the IR of meningitis cases
due to unspecified bacteria, observed between period A
and B, could be possibly linked to the simultaneous
increase in the Hib meningitis IR, reflecting the improved
isolation rates of bacterial pathogens and Hib in particu-
lar. A further reduction observed during period C is due to
the introduction and routine use of methods with higher
sensitivity and specificity, such as PCR, for the laboratory
diagnosis of bacterial meningitis.
Following, the contribution of MR is being discussed.
Medical registries are usually applied in chronic diseases
such as cancer, congenital defects, primary immunodefi-
ciencies, neurological disorders (e.g. multiple sclerosis),
renal failure and coronary artery disease [55-61]. Lately,
various studies concerning infectious diseases registries
have been published, including chronic infections e.g.
hepatitis B and HIV/AIDS [62,63], vaccine registries [64]
and Epstein Barr encephalitis registry [65].
The creation of MR in order to study an acute life-threat-
ening bacterial infection entails important benefits as well
as drawbacks. For every case selected information is gath-
ered in a systematic way and information is recorded in
hard copy, in a standard RF. The collected information
may lead to risk factors hypothesis generation, which can
be further investigated through case control and cohort
studies. Moreover, changing patterns in medical knowl-
edge and practice are reflected (e.g. changes in definitions,
diagnostic methods, and therapeutic approaches). On the
other hand, the shortcomings of the MR are related with
the long duration of the study and the high turnover of the
hospital personnel.
This is one of the weaknesses of the present study, as it is
believed to have influenced the homogeneity of the infor-
mation that was gathered. Moreover, in spite of the wide
variety of information that was planned to be collected,
certain variables presented a high number of missing
information and were excluded from the analysis.
"Another restriction of the present study is related to the
changes in referral patterns of paediatric patients with bac-
terial meningitis in Athens metropolitan area, that leaded
to a gradual decrease in the number of patients treated in
our department. In order to correctly estimate the yearly
Incidence Rate, it was presumed that the populationBMC Infectious Diseases 2007, 7:101 http://www.biomedcentral.com/1471-2334/7/101
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served by the hospital declined gradually from 100% in
period A to 65% in period B and 55% in period C, and this
assumption might have affected the quality of our assess-
ments of incidence rates. In any case the long term trend
of the incidence rates is in accordance with analysis of the
absolute numbers and the percentage of the total menin-
gitis number of cases in which no population denomina-
tor is used."
Conclusion
Neisseria meningitidis constituted the leading cause of bac-
terial meningitis in all age groups and during the whole of
the 32 years studied. Variations in the incidence of menin-
gococcal meningitis were present over time, following the
well described natural cycles that characterize the epide-
miology of meningococci. Streptococcus pneumoniae was
the most lethal pathogen involved in the etiology of bac-
terial meningitis. Haemophilus influenzae type b was an
important cause of morbidity before the implementation
of routine vaccination with conjugate vaccine, while
decreased after the vaccination introduction.
Meningitis surveillance, including the registry, is neces-
sary to monitor the disease trend, population at risk, sero-
type distribution and antimicrobial susceptibility in order
to implement appropriate public health interventions
against invasive bacterial disease. Through the present
study the MR proved to be a useful tool in the study and
the prevention of communicable diseases in correlation
with prevention strategies, such as vaccinations.
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